WallStSmart

CRH PLC ADR (CRH)vsLinde plc Ordinary Shares (LIN)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

CRH PLC ADR generates 9% more annual revenue ($38.63B vs $35.45B). LIN leads profitability with a 20.4% profit margin vs 9.9%. CRH appears more attractively valued with a PEG of 1.55. CRH earns a higher WallStSmart Score of 65/100 (C+).

CRH

Buy

65

out of 100

Grade: C+

Growth: 6.0Profit: 7.0Value: 4.7Quality: 6.5
Piotroski: 4/9Altman Z: 2.16

LIN

Buy

64

out of 100

Grade: C+

Growth: 5.3Profit: 8.0Value: 4.0Quality: 4.0
Piotroski: 3/9Altman Z: 1.49
IV

Intrinsic Value Comparison

Multi-model valuation · Graham Formula

CRHSignificantly Overvalued (-48.1%)

Margin of Safety

-48.1%

Fair Value

$59.78

Current Price

$88.55

$28.77 premium

UndervaluedFair: $59.78Overvalued
LINSignificantly Overvalued (-50.9%)

Margin of Safety

-50.9%

Fair Value

$308.97

Current Price

$466.22

$157.25 premium

UndervaluedFair: $308.97Overvalued

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CRH4 strengths · Avg: 8.5/10
Market CapQuality
$58.91B9/10

Large-cap with strong market position

Return on EquityProfitability
22.5%9/10

Every $100 of equity generates 23 in profit

P/E RatioValuation
15.5x8/10

Attractively priced relative to earnings

Price/BookValuation
2.5x8/10

Reasonable price relative to book value

LIN3 strengths · Avg: 9.0/10
Market CapQuality
$214.92B10/10

Mega-cap, among the largest globally

Profit MarginProfitability
20.4%9/10

Keeps 20 of every $100 in revenue as profit

Operating MarginProfitability
28.1%8/10

Strong operational efficiency at 28.1%

Areas to Watch

CRH1 concerns · Avg: 4.0/10
PEG RatioValuation
1.554/10

Expensive relative to growth rate

LIN4 concerns · Avg: 3.3/10
PEG RatioValuation
1.794/10

Expensive relative to growth rate

P/E RatioValuation
29.8x4/10

Moderate valuation

Piotroski F-ScoreQuality
3/93/10

Weak financial health signals

Altman Z-ScoreHealth
1.492/10

Distress zone — elevated risk

Comparative Analysis Report

WallStSmart Research

Bull Case : CRH

The strongest argument for CRH centers on Market Cap, Return on Equity, P/E Ratio.

Bull Case : LIN

The strongest argument for LIN centers on Market Cap, Profit Margin, Operating Margin. Profitability is solid with margins at 20.4% and operating margin at 28.1%.

Bear Case : CRH

The primary concerns for CRH are PEG Ratio.

Bear Case : LIN

The primary concerns for LIN are PEG Ratio, P/E Ratio, Piotroski F-Score.

Key Dynamics to Monitor

CRH profiles as a value stock while LIN is a mature play — different risk/reward profiles.

CRH carries more volatility with a beta of 1.20 — expect wider price swings.

LIN is growing revenue faster at 9.3% — sustainability is the question.

LIN generates stronger free cash flow (833M), providing more financial flexibility.

Bottom Line

CRH scores higher overall (65/100 vs 64/100). Both earn "Buy" and "Buy" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

CRH PLC ADR

BASIC MATERIALS · BUILDING MATERIALS · USA

CRH plc manufactures and distributes construction materials. The company is headquartered in Dublin, Ireland.

Visit Website →

Linde plc Ordinary Shares

BASIC MATERIALS · SPECIALTY CHEMICALS · USA

Linde plc is a multinational chemical company. It is the largest industrial gas company by market share and revenue. It serves customers in the healthcare, petroleum refining, manufacturing, food, beverage carbonation, fiber-optics, steel making, aerospace, chemicals, electronics and water treatment industries. The company's primary business is the manufacturing and distribution of atmospheric gases, including oxygen, nitrogen, argon, rare gases, and process gases, including carbon dioxide, helium, hydrogen, electronic gases, specialty gases, and acetylene.

Visit Website →

Want to dig deeper into these stocks?